218 related articles for article (PubMed ID: 35802499)
1. Phenotype-Guided Comparative Genomics Identifies the Complete Transport Pathway of the Antimicrobial Lasso Peptide Ubonodin in
Do T; Thokkadam A; Leach R; Link AJ
ACS Chem Biol; 2022 Aug; 17(8):2332-2343. PubMed ID: 35802499
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Ubonodin, an Antimicrobial Lasso Peptide Active against Members of the Burkholderia cepacia Complex.
Cheung-Lee WL; Parry ME; Zong C; Cartagena AJ; Darst SA; Connell ND; Russo R; Link AJ
Chembiochem; 2020 May; 21(9):1335-1340. PubMed ID: 31765515
[TBL] [Abstract][Full Text] [Related]
3. High-Throughput Screen Reveals the Structure-Activity Relationship of the Antimicrobial Lasso Peptide Ubonodin.
Thokkadam A; Do T; Ran X; Brynildsen MP; Yang ZJ; Link AJ
ACS Cent Sci; 2023 Mar; 9(3):540-550. PubMed ID: 36968541
[TBL] [Abstract][Full Text] [Related]
4. The Mla Pathway Plays an Essential Role in the Intrinsic Resistance of Burkholderia cepacia Complex Species to Antimicrobials and Host Innate Components.
Bernier SP; Son S; Surette MG
J Bacteriol; 2018 Sep; 200(18):. PubMed ID: 29986943
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial Lasso Peptide Cloacaenodin Utilizes a Unique TonB-Dependent Transporter to Access Susceptible Bacteria.
Carson DV; Juarez RJ; Do T; Yang ZJ; Link AJ
ACS Chem Biol; 2024 Apr; 19(4):981-991. PubMed ID: 38527226
[TBL] [Abstract][Full Text] [Related]
6. Comparative Genomics and Evolutionary Analysis of RNA-Binding Proteins of
Feliciano JR; Seixas AMM; Pita T; Leitão JH
Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32098200
[TBL] [Abstract][Full Text] [Related]
7. Resistance of the Burkholderia cepacia complex to fosmidomycin and fosmidomycin derivatives.
Messiaen AS; Verbrugghen T; Declerck C; Ortmann R; Schlitzer M; Nelis H; Van Calenbergh S; Coenye T
Int J Antimicrob Agents; 2011 Sep; 38(3):261-4. PubMed ID: 21724375
[TBL] [Abstract][Full Text] [Related]
8. Screening a mushroom extract library for activity against Acinetobacter baumannii and Burkholderia cepacia and the identification of a compound with anti-Burkholderia activity.
Schwan WR; Dunek C; Gebhardt M; Engelbrecht K; Klett T; Monte A; Toce J; Rott M; Volk TJ; LiPuma JJ; Liu XT; McKelvey R
Ann Clin Microbiol Antimicrob; 2010 Jan; 9():4. PubMed ID: 20092635
[TBL] [Abstract][Full Text] [Related]
9. Use of Synthetic Hybrid Strains To Determine the Role of Replicon 3 in Virulence of the Burkholderia cepacia Complex.
Agnoli K; Freitag R; Gomes MC; Jenul C; Suppiger A; Mannweiler O; Frauenknecht C; Janser D; Vergunst AC; Eberl L
Appl Environ Microbiol; 2017 Jul; 83(13):. PubMed ID: 28432094
[TBL] [Abstract][Full Text] [Related]
10. Relaxed specificity of BcpB transporters mediates interactions between
Elery ZK; Myers-Morales T; Phillips ED; Garcia EC
mSphere; 2023 Aug; 8(4):e0030323. PubMed ID: 37498085
[TBL] [Abstract][Full Text] [Related]
11. Biosynthesis of Ditropolonyl Sulfide, an Antibacterial Compound Produced by Burkholderia cepacia Complex Strain R-12632.
Depoorter E; Coenye T; Vandamme P
Appl Environ Microbiol; 2021 Oct; 87(22):e0116921. PubMed ID: 34524894
[TBL] [Abstract][Full Text] [Related]
12. Diversity of the parB and repA genes of the Burkholderia cepacia complex and their utility for rapid identification of Burkholderia cenocepacia.
Drevinek P; Baldwin A; Dowson CG; Mahenthiralingam E
BMC Microbiol; 2008 Mar; 8():44. PubMed ID: 18328098
[TBL] [Abstract][Full Text] [Related]
13. "Switching Partners": Piperacillin-Avibactam Is a Highly Potent Combination against Multidrug-Resistant
Zeiser ET; Becka SA; Wilson BM; Barnes MD; LiPuma JJ; Papp-Wallace KM
J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167848
[TBL] [Abstract][Full Text] [Related]
14. Mapping the Efficacy and Mode of Action of Ethylzingerone [4-(3-Ethoxy-4-Hydroxyphenyl) Butan-2-One] as an Active Agent against
Rushton L; Khodr A; Menard-Szczebara F; Maillard JY; Cupferman S; Mahenthiralingam E
Appl Environ Microbiol; 2020 Sep; 86(19):. PubMed ID: 32737133
[No Abstract] [Full Text] [Related]
15. Preliminary data on antibacterial activity of Echinacea purpurea-associated bacterial communities against Burkholderia cepacia complex strains, opportunistic pathogens of Cystic Fibrosis patients.
Chiellini C; Maida I; Maggini V; Bosi E; Mocali S; Emiliani G; Perrin E; Firenzuoli F; Mengoni A; Fani R
Microbiol Res; 2017 Mar; 196():34-43. PubMed ID: 28164789
[TBL] [Abstract][Full Text] [Related]
16. [Advances in virulence determinants in Burkholderia cepacia complex--a review].
Tang Q; Zhu H; Qin W
Wei Sheng Wu Xue Bao; 2014 May; 54(5):487-97. PubMed ID: 25199247
[TBL] [Abstract][Full Text] [Related]
17. Burkholderia cepacia complex infections: More complex than the bacterium name suggest.
Sfeir MM
J Infect; 2018 Sep; 77(3):166-170. PubMed ID: 30012345
[TBL] [Abstract][Full Text] [Related]
18. Hypermutation in Burkholderia cepacia complex is mediated by DNA mismatch repair inactivation and is highly prevalent in cystic fibrosis chronic respiratory infection.
Martina P; Feliziani S; Juan C; Bettiol M; Gatti B; Yantorno O; Smania AM; Oliver A; Bosch A
Int J Med Microbiol; 2014 Nov; 304(8):1182-91. PubMed ID: 25217078
[TBL] [Abstract][Full Text] [Related]
19. Genome characterization of a novel Burkholderia cepacia complex genomovar isolated from dieback affected mango orchards.
Khan A; Asif H; Studholme DJ; Khan IA; Azim MK
World J Microbiol Biotechnol; 2013 Nov; 29(11):2033-44. PubMed ID: 23653265
[TBL] [Abstract][Full Text] [Related]
20. Combination antimicrobial susceptibility testing of Burkholderia cepacia complex: significance of species.
Abbott FK; Milne KE; Stead DA; Gould IM
Int J Antimicrob Agents; 2016 Nov; 48(5):521-527. PubMed ID: 27665523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
